Skip to content

Study · Randomized controlled trial · n = 60 · 1989

2 results

The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children.

Seear MD, Wadsworth LD, Rogers PC, Sheps S, Ashmore PG

The Journal of thoracic and cardiovascular surgery1 Aug 1989Cited by 49 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanRandomized controlled trialEfficacy outcome

    In children after cardiac surgery, blood loss did not differ significantly: 40.0 +/- 33.1 ml/kg with desmopressin versus 30.5 +/- 37.9 with placebo.

    In plain wordsIn children after cardiac surgery, desmopressin did not significantly change blood loss compared with placebo.

    Outcome
    No significant changePostoperative blood loss
    Study

    n = 60

    Comparator
    Saline placebo
    Outcome group
    Bleeding and clotting · Whole body
    Studied dose
    0.3 microgram/kg · intravenousAs given in this study (human).

    Measurements

    Postoperative blood loss
    40 ml/kg
    desmopressin group, +/- 33.1
    Postoperative blood loss
    30.5 ml/kg
    placebo group, +/- 37.9

    Source sentences

    Summary
    Results showed no significant difference in postoperative blood loss between the two groups (30.5 +/- 37.9 ml/kg in the placebo group versus 40.0 +/- 33.1 ml/kg in the desmopressin group).
    2 context sentences
    Summary · context
    We investigated the effect of an intraoperative desmopressin acetate infusion on blood loss after cardiac operation in 60 children, by using a prospective, randomized, double-blind trial.
    Summary · context
    Thirty patients received a desmopressin dose of 0.3 microgram/kg intravenously over 15 minutes at the conclusion of cardiac bypass, and 30 received a saline placebo.
  2. 02HumanRandomized controlled trialEfficacy outcome

    In children after cardiac surgery, desmopressin and placebo did not differ significantly in bleeding time, urine output, hemodynamics, or coagulation studies.

    In plain wordsIn children after cardiac surgery, bleeding time, urine output, hemodynamics, and coagulation tests did not differ significantly between desmopressin and placebo.

    Outcome
    No significant changePostoperative bleeding time, urine output, hemodynamics and coagulation
    Study

    n = 60

    Comparator
    Saline placebo
    Outcome group
    Postoperative Outcomes · Whole body
    Studied dose
    0.3 microgram/kg · intravenousAs given in this study (human).

    Source sentences

    Summary
    Postoperative bleeding time, total urine output, postinfusion hemodynamics, and postoperative coagulation studies did not differ significantly between the two groups.
    2 context sentences
    Summary · context
    We investigated the effect of an intraoperative desmopressin acetate infusion on blood loss after cardiac operation in 60 children, by using a prospective, randomized, double-blind trial.
    Summary · context
    Thirty patients received a desmopressin dose of 0.3 microgram/kg intravenously over 15 minutes at the conclusion of cardiac bypass, and 30 received a saline placebo.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:35 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.